Access Resources
6871 - 6880 of 7562 Results
Title
Year
- Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex2013RESTRICTEDTitle: Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complexJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 242End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.05.017Best OA location URL: https://europepmc.org/articles/pmc3490034?pdf=renderCitation Count: 40
- The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease2013RESTRICTEDTitle: The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 187End Page: 195Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.029Best OA location URL: https://europepmc.org/articles/pmc3432150?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: The natural history of multiple system atrophy: a prospective European cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 3Start Page: 264End Page: 274Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7Best OA location URL: http://www.thelancet.com/article/S1474442212703277/pdfCitation Count: 427
- Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm2013RESTRICTEDTitle: Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasmJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 9Start Page: 1345End Page: 1353Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-0998-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-0998-9.pdfCitation Count: 51
-
RESTRICTEDTitle: Human α4β2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric α-SynucleinJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 2Start Page: e55886End Page: e55886Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0055886Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0055886&type=printableCitation Count: 12
-
RESTRICTEDTitle: Validation of nigrostriatal positron emission tomography measures: Critical limitsJournal Name: Annals of NeurologyPublisher: WileyVol: 73Issue #: 3Start Page: 390End Page: 396Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.23798Best OA location URL: https://europepmc.org/articles/pmc3631302?pdf=renderCitation Count: 72
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)2013RESTRICTEDTitle: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187Citation Count: 0
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 0
- Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent2013RESTRICTEDTitle: Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging AgentJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 2Start Page: e55031End Page: e55031Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0055031Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0055031&type=printableCitation Count: 102
-
RESTRICTEDTitle: Which dyskinesia scale best detects treatment response?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 341End Page: 346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25321Citation Count: 76